SEAFIELD CAPITAL CORP
PRES14A, 1997-09-05
MEDICAL LABORATORIES
Previous: LORD ABBETT GLOBAL FUND INC, N-30D, 1997-09-05
Next: WARREN BANCORP INC, 8-K/A, 1997-09-05



                          SCHEDULE 14A INFORMATION

                 Proxy Statement Pursuant to Section 14(a) of
            the Securities Exchange Act of 1934 (Amendment No.    )

Filed by the Registrant /x/
Filed by a Party other than the Registrant  / /

Check the appropriate box:
/x/    Preliminary Proxy Statement
/ /    Confidential, for Use of the Commission Only (as permitted by
       Rule 14a-6(e)(2))
/ /    Definitive Proxy Statement
/ /    Definitive Additional Materials
/ /    Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12

                         Seafield Capital Corporation			
              ---------------------------------------------------
              (Name of Registrant as Specified In Its Charter)

- -------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):
/x/    No fee required
/ /    Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11
       (1)  Title of each class of securities to which transaction applies:

            ---------------------------------------------------------------
       (2)  Aggregate number of securities to which transaction applies:

            ---------------------------------------------------------------
       (3)  Per unit price or other underlying value of transaction computed
            pursuant to Exchange Act Rule 0-11 (set forth the amount on which
            the filing fee is calculated and state how it was determined:

            ---------------------------------------------------------------
       (4)  Proposed maximum aggregate value of transaction:

            ---------------------------------------------------------------
       (5)  Total fee paid:

            ---------------------------------------------------------------
/ /    Fee paid previously with preliminary materials
/ /    Check box if any part of the fee is offset as provided by Exchange Act
       Rule 0-11(a)(2) and identify the filing for which the offsetting fee
       was paid previously.  Identify the previous filing by registration
       statement number, or the Form or Schedule and the date of its filing.
       (1)  Amount Previously Paid

            ---------------------------------------------------------------
       (2)  Form, Schedule or Registration Statement No.:

            ---------------------------------------------------------------
       (3)  Filing Party:

            ---------------------------------------------------------------
       (4)  Date Filed:

            ---------------------------------------------------------------


          PRELIMINARY, SUBJECT TO COMPLETION OR AMENDMENT

                   SEAFIELD CAPITAL CORPORATION
                 5000 West 95th Street, Suite 260
                       Post Office Box 7568
                  Shawnee Mission, Kansas  66207

                           ___________

              NOTICE OF SPECIAL MEETING OF SHAREHOLDERS
                   To be held on October 15, 1997

                           ___________

A Special Meeting of Shareholders of Seafield Capital 
Corporation (the "Company") will be held on Wednesday, October 15, 
1997, at 10:00 a.m., local time at the offices of LabOne, Inc., 
located at 10310 W. 84th Terrace, Lenexa, Kansas for the following 
purposes: 

     1.  To consider and vote upon a proposal to approve an amendment 
         to the Company's Articles of Incorporation changing its name from 
         Seafield Capital Corporation to Lab Holdings, Inc.;

     2.  To transact such other business as may properly come before 
         the meeting or any adjournment thereof.

The Board of Directors of the Company has established September 
5, 1997 as the record date for the meeting. Shareholders of record at 
the close of business on that day will be entitled to vote at the 
Special Meeting and any adjournments thereof. 

You are cordially invited to attend this meeting. It is 
important that your stock be represented at the meeting. Even if you 
plan to attend the meeting, you are urged to complete, sign and 
return the enclosed proxy card as soon as possible to ensure that 
your shares will be represented at the meeting. If you attend the 
meeting, you may revoke your proxy by voting in person.

                               By Order of the Board of Directors,



                               P. ANTHONY JACOBS
                               President



                               STEVEN K. FITZWATER
                               Secretary

September __, 1997










    PRELIMINARY PROXY STATEMENT, SUBJECT TO COMPLETION OR AMENDMENT
   
                   SEAFIELD CAPITAL CORPORATION
                  5000 West 95th Street, Suite 260
                        Post Office Box 7568
                    Shawnee Mission, Kansas  66207

                            ___________

                          PROXY STATEMENT
                            ___________
 
                    Special Meeting of Shareholders
                     to be held on October 15, 1997

                            ___________

                           INTRODUCTION
  
This Proxy Statement is being furnished to the shareholders 
of Seafield Capital Corporation, a Missouri corporation (the 
"Company"), in connection with the solicitation of proxies by the 
Board of Directors of the Company for use at a Special Meeting of 
Shareholders of the Company to be held on Wednesday, October 15, 
1997, and any adjournments thereof. The address of the principal 
executive offices of the Company is 5000 West 95th Street, Suite 
260, Post Office Box 7568, Shawnee Mission, Kansas 66207. The 
telephone number at that address is (913) 652-1000. The 
distribution to shareholders of this Proxy Statement, together 
with the accompanying proxy materials, will commence on or about 
September ___, 1997. 

At the Special Meeting, shareholders will be asked to 
approve an amendment to the Company's Articles of Incorporation 
changing its name from Seafield Capital Corporation to Lab 
Holdings, Inc., as set forth in the Proxy Statement. 

                   VOTING AND PROXIES

The Board of Directors of the Company has established 
September 5, 1997 as the record date for the meeting. Only 
shareholders of record at the close of business on the record 
date are entitled to notice of and to vote at the Special 
Meeting, and any adjournments thereof. At the close of business 
on the record date, the Company had outstanding 6,489,103 shares 
of Common Stock, par value $1.00 per share ("Common Stock" or 
"Company Common Stock"). Each share of Company Common Stock 
outstanding on the record date is entitled to one vote.  The 
presence in person or by proxy of the holders of record of a 
majority of the shares of Company Common Stock entitled to a vote 
at the Special Meeting shall constitute a quorum for the 
transaction of business at the meeting.  Shares represented by a 
proxy which directs that the shares abstain from voting or that a 
vote be withheld on a matter shall be deemed to be represented at 
the Special Meeting for quorum purposes.

The affirmative vote of the holders of a majority of the 
issued and outstanding shares of Common Stock is required to 
approve the proposed amendment to the Company's Articles of 
Incorporation changing its name to Lab Holdings, Inc.  For 
purposes of such approval, shares represented by a proxy which 
directs that the shares abstain from voting and broker non-votes 
shall be deemed voted AGAINST such approval.  Broker non-votes 
will not be counted as either FOR or AGAINST any other matter 
that may properly come before the Special Meeting.

All shares of Company Common Stock represented by a properly 
executed form of proxy received by the Board of Directors 
pursuant to this solicitation will be voted in accordance with 
the instructions, if any, given in such proxy. If a form of proxy 
is duly executed but does not specify the manner in which the 
shares should be voted on any matter or matters, the proxy will 
be voted in accordance with the recommendations of the Company's 
Board of Directors as set forth herein. A proxy may be revoked at 
any time prior to the exercise thereof by a notice from the 
shareholder received in writing by the Secretary of the Company, 
by submission of a duly executed form of proxy bearing a later 
date, or by voting in person at the Special Meeting. 

The entire cost of this proxy solicitation will be borne by 
the Company. The Company will make arrangements with brokerage 
firms, banks, nominees, fiduciaries and other custodians to 
supply proxy materials to beneficial owners of Company Common 
Stock and will reimburse them for their expenses in so doing. In 
addition to solicitation by mail, proxies may be solicited by the 
directors, officers and employees of the Company by personal 
interview, telegraph, telephone or additional mailings. Such 
directors, officers and employees will not be additionally 
compensated for such solicitation, but may be reimbursed for 
expenses in connection therewith. 

        PROPOSED AMENDMENT TO ARTICLES OF INCORPORATION

Introduction

The Board of Directors believes that the Company's name 
should be changed to better identify the Company with its primary 
asset, an 82% ownership of LabOne, Inc.  To reflect the Company's 
recently narrowed focus on the clinical and insurance laboratory 
testing businesses of LabOne, Inc.,  the Board of Directors 
proposes that the Company's name be changed to Lab Holdings, Inc. 
 

History

Following the sale of the Company's insurance operations in 
1990, its name was changed to Seafield Capital Corporation.  At 
that time, the Company was a diversified holding company whose 
assets consisted not only of a majority ownership of LabOne, Inc. 
(then named Home Office Reference Laboratory, Inc.), but also a 
substantial ownership position in Response Oncology, Inc. (then 
named Response Technology, Inc.), and several investments in 
health care and insurance services businesses, as well as real 
estate and energy ventures.

Since early 1995, the Company has sold several of its non-
core businesses.  In early 1997, the Company distributed to its 
shareholders all of the stock of SLH Corporation ("SLH"), a 
former wholly-owned subsidiary to which the Company had 
contributed assets constituting the Company's real estate and 
energy businesses as well as certain other miscellaneous assets. 
SLH stock is a National Market System security, traded on the 
NASDAQ Stock Market under the symbol "SLHO".  In July 1997, the 
Company distributed to its shareholders those shares of Response 
Oncology, Inc. ("Response") formerly owned by the Company 
(consisting of approximately two-thirds of all Response shares 
outstanding).  Response stock is a National Market System 
security, traded on the NASDAQ Stock Market under the symbol 
"ROIX".

As a result of all of the transactions described above, the 
Company's holdings now include only a small amount of cash and 
marketable securities (approximately $ 4.7 million) and 
10,712,200 shares of LabOne, Inc. (constituting approximately 82% 
of all LabOne, Inc. shares outstanding).

In keeping with the recent reduction in the Company's assets 
and the narrowed focus of its holdings, the Board of Directors 
has been reduced to four (4) members, whose names are shown in 
the table which follows under the heading "Security Ownership of 
Management".  In addition, while the Company has a President and 
Secretary (both of whom are also Directors), the Company now has 
no salaried employees.  All administrative functions of the 
Company formerly performed by Company personnel will be provided 
on a contract basis at an annual cost to the Company of $75,000.

All matters referred to under this caption "History" are for 
informational purposes only.  No shareholder consent approval or 
other action is sought with respect thereto.

Proposal

The Board of Directors is recommending to shareholders that 
Article I of the Company's Articles of Incorporation be amended 
so that as amended, said Article I will read in its entirety as 
follows:

    "The name of this corporation is Lab Holdings, Inc."

If this amendment is approved, upon filing of Articles of 
Amendment with the Secretary of State of the State of Missouri, 
the name of the Company will be changed from Seafield Capital 
Corporation to Lab Holdings, Inc.

The approval of the holders of a majority of the issued and 
outstanding shares of common stock on the record date for the 
Special Meeting is required to approve the foregoing amendment to 
the Company's Articles of Incorporation.

The Board of Directors recommends that shareholders vote FOR 
this amendment.


Security Ownership of Management

The following table and notes thereto indicate the shares of 
Company Common Stock and of the common stock of the Company's 
majority-owned subsidiary, LabOne, Inc. ("LabOne"), known to the 
Company to be beneficially owned as of August 31, 1997, by each 
director of the Company, each of the executive officers of the 
Company and by all directors and executive officers of the 
Company as a group.


Name            Shares of Company Common   Percentage of    Shares of Common
                Stock Beneficially Owned     Class(6)       Stock of LabOne
                        (1)(5)                              Beneficially Owned
                                                              (1) (7) (8)

Lan C. Bentsen,
a Director                 8,326 (2)            --                --

Steven K. Fitzwater, 
Vice President, 
Secretary and a 
Director                   3,145                --                  5

W. T. Grant II, Chief 
Executive Officer of 
LabOne, Inc. 	         146,876 (3)           2.3%            29,231

P. Anthony Jacobs, 
President and a 
Director                  18,987                --             23,500

John H. Robinson, Jr,
a Director                10,116                --                --

All directors and 
executive officers as 
a group (5 persons)      186,260 (4)           2.9%            52,731      
    

___________

 (1) A beneficial owner of a security includes a person who, 
directly or indirectly, has or shares voting or investment power 
with respect to such security. Voting power is the power to vote 
or direct the voting of the security and investment power is the 
power to dispose or direct the disposition of the security. Each 
person listed has stated that he, either alone or with his 
spouse, has sole voting power and sole investment power with 
respect to the shares shown as beneficially owned, except as 
otherwise indicated. 

 (2) Includes 1,432 shares held by a family trust for the benefit 
of Mr. Bentsen's children, as to which he disclaims beneficial 
ownership. Mr. Bentsen is trustee with sole voting and investment 
powers. 

 (3) Includes 31,259 shares held by W. T. Grant II as custodian 
for his children; includes 45,000 shares held in a family trust 
for which W. T. Grant II serves as a co-trustee and in that 
capacity shares voting and investment powers; also includes 
11,870 shares owned by the wife of W. T. Grant II, as to which he 
disclaims beneficial ownership. 

 (4) Includes an aggregate of 1,213 shares held under the 
Seafield Capital Corporation 401(k) Plan and Trust (based upon 
the Plan statement as of June 30, 1997) which are held in a trust 
of which The Investors Services Trust Company is the trustee, but 
as to which the trustee is obligated to grant voting rights to 
the Plan Administrative Committee, comprising an executive 
officer of the Company, if requested by said Committee. 

 (5) Includes as to W. T. Grant II 1,190 shares held in his 
account under the Seafield Capital Corporation 401(k) Plan and 
Trust as of June 30, 1997 (based on a plan statement of that 
date), as to which he shares investment power but does not have 
voting power; in the case of Mr. Fitzwater all  1,213 shares held 
in the 401(k) Plan are included because he shares voting power as 
a member of the 401(k) Plan Administrative Committee.

 (6) The percentages represent the total number of shares of 
Common Stock shown in the adjacent column divided by the number 
of issued and outstanding shares of Common Stock as of August 31, 
1997 (6,489,103 shares).  Percentages of less than one percent 
are omitted. 

 (7) Shares of LabOne stock shown as beneficially owned include 
shares issuable upon the exercise of stock options granted under 
the LabOne Long-Term Incentive Plan that were exercisable on 
August 31, 1997 or that become exercisable within 60 days 
thereafter, as follows: W. T. Grant II, 27,431 shares; P. Anthony 
Jacobs, 22,000 shares; and all directors and executive officers 
as a group, 49,431 shares

 (8) Percentages of shares beneficially owned are less than 1% 
for all directors and executive officers individually and as a 
group; the shares shown as beneficially owned do not include 
10,712,200 shares of LabOne owned by the Company as to which each 
director of the Company has shared voting and investment power as 
a member of the Company's Board of Directors.  Each Board member 
disclaims beneficial ownership of the LabOne shares owned by 
Seafield.


Security Ownership of Certain Beneficial Owners

The following table indicates the shares of Company Common 
Stock beneficially owned by the only persons known to the Company 
or its management as beneficially owning more than five percent 
of the Company's Common Stock as of August 31, 1997.

     Name and Address of            Amount and Nature               Percent of
      Beneficial Owner           of Beneficial Ownership             Class (1)

American Century Companies,Inc.   Total 426,300 (2)                     6.6%
4500 Main Street                    sole voting power        426,300
P. O. Box 418210                    shared voting power       -0-
Kansas City, Missouri               sole disposition power   426,300  
64141-9210                          shared disposition power  -0-

__________

(1)	The percentage represents the total numbers of shares of 
Common Stock shown in the adjacent column divided by the number 
of issued and outstanding shares of Common Stock as of August 31, 1997. 

(2)	As reported in a Schedule 13G filing as of December 31, 1996.


                 SHAREHOLDER PROPOSALS

Shareholder proposals intended for inclusion in the proxy 
materials of the Company for the 1998 Annual Meeting must be 
received by the Company at its executive offices on or before 
December 20, 1997, in order to be eligible for inclusion therein. 


	            OTHER BUSINESS


As of the date of this Proxy Statement, the Board of 
Directors is not aware of any matters to be presented for action 
at the Special Meeting other than those described herein. The 
Company's Bylaws restrict the business conducted at a special 
meeting of shareholders to the purposes stated in the Notice of 
such meeting, unless the transaction of other business is 
consented to by the holders of all of the outstanding shares of 
stock of the corporation entitled to vote thereat.  If any other 
matters should properly come before the Special Meeting, it is 
the intention of each of the persons named on the enclosed form 
of proxy to vote all duly executed proxies in accordance with 
their best judgment on such matters.


                               By Order of the Board of Directors


                               Steven K. Fitzwater,
                               Secretary

Shawnee Mission, Kansas
September ___, 1997






















                 SEAFIELD CAPITAL CORPORATION

          Proxy Solicited by the Board of Directors


The undersigned hereby constitutes and appoints P. Anthony 
Jacobs and Steven K. Fitzwater, and each of them, jointly and 
severally, as proxies, with fully power of substitution and 
revocation, for and in the name and place of the undersigned, to vote 
all of the shares of $1.00 par value common stock of Seafield Capital 
Corporation, a Missouri corporation (the "Company"), which the 
undersigned is entitled to vote at a Special Meeting of shareholders 
of the Company to be held at the offices of LabOne, Inc., 10310 W. 
84th Terrace, Lenexa, Kansas, on Wednesday, October, 15, 1997, at 
10:00 a.m. local time, and at any adjournment or adjournments 
thereof, as fully and with the same effect as the undersigned might 
or could do if personally present, as indicated on the reverse side 
of this card.

	(To be signed on Reverse Side)	[See Reverse Side]


  ___    Please mark your
 / x /   votes as in this
 /___/   example.

                                                 FOR     AGAINST     ABSTAIN

1.  Approval of a proposal to amend the         /  /      /  /        /  /
    Company's Articles of Incorporation 
    changing its name to Lab Holdings, Inc.
    (proposal made by the Company)

2.  In their discretion upon all other matters	/  /     /  /        /  /

                            The Board of Directors recommends a vote FOR each
                            of the proposals described above.  If you sign and
                            return this proxy it will be voted in the manner
                            directed herein.  IF YOU DO NOT DESIGNATE HOW YOUR
                            SHARES ARE TO BE VOTED THE PROXY WILL BE VOTED FOR
                            EACH PROPOSAL.

                            If you do not mark any boxes in Items (1) and (2),
                            you will be deemed to have granted authority to 
                            the named proxies to vote for the proposal in Item
                            1 and to vote in their discretion on all other 
                            matters which may properly come before the meeting.

PLEASE MARK, SIGN, DATE AND RETURN THE PROXY CARD PROMPTLY USING THE ENCLOSED 
ENVELOPE.

SIGNATURE(S)________________________________________________________
	DATE___________________________________
Note:	Please sign exactly as name appears hereon.  Joint owners should each 
sign.  When signing as attorney, executor, administrator, trustee or 
guardian, please give full title as such.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission